Future Prospects of the Focal Adhesion Kinase Market 2035

added blog Health

2026-09-09 05:14:06 -

Navigating Clinical Development Challenges and Biomarker Integration Despite the compelling biological rationale for targeting Focal Adhesion Kinase (FAK), navigating the pathway to commercial approval presents clinical and diagnostic challenges. Monotherapy trials using early-generation FAK inhibitors often demonstrated limited single-agent efficacy, emphasizing that FAK blockade is rarely...

0 Comments 0 Shares 25 Views 0 Reviews